IT1247694B - Calcitonin-based pharmaceutical compositions administrable by the nasal route - Google Patents
Calcitonin-based pharmaceutical compositions administrable by the nasal routeInfo
- Publication number
- IT1247694B IT1247694B IT04806390A IT4806390A IT1247694B IT 1247694 B IT1247694 B IT 1247694B IT 04806390 A IT04806390 A IT 04806390A IT 4806390 A IT4806390 A IT 4806390A IT 1247694 B IT1247694 B IT 1247694B
- Authority
- IT
- Italy
- Prior art keywords
- calcitonin
- pharmaceutical compositions
- nasal route
- based pharmaceutical
- compositions administrable
- Prior art date
Links
- 102000055006 Calcitonin Human genes 0.000 title abstract 2
- 108060001064 Calcitonin Proteins 0.000 title abstract 2
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title abstract 2
- 229960004015 calcitonin Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000012062 aqueous buffer Substances 0.000 abstract 1
- 239000003755 preservative agent Substances 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
The objects of the invention are pharmaceutical compositions suitable for administration by the nasal route comprising: a) calcitonin, b) an antibacterial preservative, c) a carrier absorption activator, and d) an appropriate aqueous buffer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT04806390A IT1247694B (en) | 1990-06-14 | 1990-06-14 | Calcitonin-based pharmaceutical compositions administrable by the nasal route |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT04806390A IT1247694B (en) | 1990-06-14 | 1990-06-14 | Calcitonin-based pharmaceutical compositions administrable by the nasal route |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IT9048063A0 IT9048063A0 (en) | 1990-06-14 |
| IT9048063A1 IT9048063A1 (en) | 1991-12-14 |
| IT1247694B true IT1247694B (en) | 1994-12-30 |
Family
ID=11264294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT04806390A IT1247694B (en) | 1990-06-14 | 1990-06-14 | Calcitonin-based pharmaceutical compositions administrable by the nasal route |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | IT1247694B (en) |
-
1990
- 1990-06-14 IT IT04806390A patent/IT1247694B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IT9048063A0 (en) | 1990-06-14 |
| IT9048063A1 (en) | 1991-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW272195B (en) | ||
| IL128425A0 (en) | Taxane derivatives their preparation and pharmaceutical compositions containing them | |
| FI925615A0 (en) | PHARMACEUTICAL COMPOSITION OF THE STABILIZER, SOM INNEHAOLLER EN HMG-COA-REDUKTAS-INHIBITORFOERENING | |
| DE69311556T2 (en) | INHALATION POWDER CONTAINING ANTISTATIC AUXILIARY AGENT | |
| ITRM910696A0 (en) | PHARMACEUTICAL COMPOSITIONS FOR NASAL APPLICATION. | |
| ITRM920361A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING AN ALLYLAMINIC COMPOUND AS THE ACTIVE INGREDIENT. | |
| GR3031711T3 (en) | Cephalosporins and homologues, preparations and pharmaceutical compositions. | |
| NO950799L (en) | Orally administrable pharmaceutical preparations | |
| IL107554A (en) | Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them | |
| ES2072442T3 (en) | PHARMACEUTICAL COMPOSITIONS. | |
| FR2425856B1 (en) | ||
| IT1247694B (en) | Calcitonin-based pharmaceutical compositions administrable by the nasal route | |
| DK0577745T3 (en) | Bis-naphthalimides containing amide and thioamide compounds as anticancer agents. | |
| IT1247695B (en) | Calcitonin-based pharmaceutical compositions administrable by the nasal route in human therapy | |
| HK1012242A1 (en) | Topical composition containing penciclovir | |
| NZ228023A (en) | 24(r)-scymnol; preparatory processes and pharmaceutical compositions | |
| DE69005241D1 (en) | Pharmaceutical compositions containing calcitonin. | |
| NL192325B (en) | Aqueous nasal pharmaceutical composition containing dehydroergotamine and spray delivery device. | |
| AU8744691A (en) | N-((2-thenoylmercapto-3-methyl)-butanoyl)-homocysteine thiolactone, a process for the preparation thereof and pharmaceutical compositions containing it | |
| DE69208913D1 (en) | Medicament containing 2-oxindole-1-carboxamide derivative for rectal administration | |
| SE8503513D0 (en) | PHARMACEUTICAL AND COSMETIC COMPOSITIONS WHICH ACTIVE INGREDIENT INCLUDE ACETYL-10-TRIACETOXI-1,8,9-ANTRACEN | |
| IT1244601B (en) | Pharmaceutical compositions for the intranasal administration of calcitonin. | |
| IT1233376B (en) | Pharmaceutical formula containing N-acetyl-cysteine | |
| IT1273460B (en) | Pharmaceutical formulations having antiviral action for topical use | |
| ITRM920551A1 (en) | INTRANASALLY ADMINISTRABLE PHARMACEUTICAL COMPOSITIONS CONTAINING CALCITONIN AS THE ACTIVE INGREDIENT. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19940628 |